quantisnow
FeedTopReportsPricing
⌘K
Live feed
05:36:42·821d
NEWSRelease
Apollo Medical Holdings Inc. logo

Stifel Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $45

AMEH· Apollo Medical Holdings Inc.
Consumer Discretionary
Original source

Companies

  • AMEH
    Apollo Medical Holdings Inc.
    Consumer Discretionary

Recent analyst ratings

  • Feb 22UpdateBofA Securities$55.00
  • Jan 24UpdateStifel$45.00
  • Dec 22UpdateTruist$41.00
  • Oct 17UpdateBTIG Research$45.00
  • Apr 12UpdateBofA Securities$44.00
  • Dec 19UpdateLake Street$40.00

Related

  • SEC785d
    Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
  • NEWS786d
    Apollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M Estimate
  • SEC786d
    Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • NEWS787d
    Apollo Medical Hlgs's Earnings Outlook
  • NEWS788d
    Jefferies Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $50
  • SEC788d
    Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • NEWS791d
    Apollo shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $44 to $55.
  • NEWS792d
    B of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022